Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05744648
Status:
COMPLETED
Last Update Posted:
2023-09-13
First Post:
2023-02-16
Brief Title:
Efficacy of Nanoparticle-incorporated Bonding Agent on Post-restorative Sensitivity
Sponsor:
Pakistan Institute of Medical Sciences
Organization:
Pakistan Institute of Medical Sciences
Study Overview
Official Title:
Clinical Efficacy of a Novel Titania Nanoparticle-Reinforced Bonding Agent in Reducing Post-Restorative Sensitivity A Randomized Clinical Trial
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Type of study Randomized Clinical trial To compare post-restorative sensitivity between titania nanoparticle reinforced bonding agent and bonding agent without nanoparticles in posterior composite restorations
Participants aged 18 years and above with Class-I and Class-II Carious lesions are allocated in two groups Group A will undergo composite restoration with Nanoparticles incorporated in bonding agent Group B will undergo restoration without nanoparticles in bonding agent
Participants aged 18 years and above with Class-I and Class-II Carious lesions are allocated in two groups Group A will undergo composite restoration with Nanoparticles incorporated in bonding agent Group B will undergo restoration without nanoparticles in bonding agent
Detailed Description:
In this study Novel titania nanoparticle reinforced bonding agent will be evaluated for post-restorative sensitivity in composite restorations Participants following the Inclusion criteria will be allocated in this study by Consecutive non-random sampling technique Participants will be divided into two groups A and B After rubber dam isolation carious lesion will be excavated In group A titania nanoparticle reinforced bonding agent will be used for restorative treatment while in group B Bonding agent without nanoparticles will be used Post-restorative sensitivity record will be taken at 24 hours after one week and after one month Sensitivity will be assessed using Visual analog scale VAS mean score
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None